On 7 July 2025, IARC released data indicating that a 4.5 kg/m² increase in BMI was associated with a 13% higher breast cancer risk among post‑menopausal women without cardiovascular disease (CVD), and a 31% increase among those with CVD. The study emphasizes the amplified risk posed by obesity when combined with cardiometabolic conditions and supports integrated prevention strategies addressing weight management and comorbidity
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959